Non-adherence to anti-tuberculosis treatment among internal migrants with pulmonary tuberculosis in Shenzhen, China: A cross-sectional study

BMC Public Health

Volumn 15, Issue 1, 2015, Pages

  Tang, Ying ^a,b   Zhao, Meigui ^a,b   Wang, Yunxia ^a,b   Gong, Yanhong ^c   Yin, Xiaoxv ^c   Zhao, Angui ^a,b   Zheng, Juanjuan ^a,b   Liu, Zhenyang ^a,b   Jian, Xiaofang ^a,b   Wang, Wenxin ^d   Wu, Chunmei ^c   Lu, Zuxun ^c  

^a Bao'an District Key Medical Department of Tuberculosis Prevention and Control Bao'an District Hospital for Chronic Diseases Prevention and Cure   (China)

^b Bao'an District Hospital for Chronic Diseases Prevention and Cure   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d JIANGSU UNIVERSITY   (China)

Author keywords

Compliance; Migrants; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; AGED; ATTITUDE TO HEALTH; CHINA; CROSS-SECTIONAL STUDY; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; MALE; MIDDLE AGED; MIGRATION; PATIENT COMPLIANCE; PROCEDURES; QUALITATIVE RESEARCH; RISK FACTOR; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

ADULT; AGED; ANTITUBERCULAR AGENTS; ATTITUDE TO HEALTH; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PROCESS ASSESSMENT (HEALTH CARE); QUALITATIVE RESEARCH; RISK FACTORS; TRANSIENTS AND MIGRANTS; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84929319046     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-015-1789-z     Document Type: Article

References (22)

1. World Health Organization. Global tuberculosis report 2013. Genava: WHO Press; 2014.
2. National Technical Steering Group of the Epidemiological Sampling Survey for Tuberculosis. The Fifth National Tuberculosis Epidemiological Survey in 2010. Chin J Anti-tubrculosis. 2012;34:485-508.
3. Yin X, Tu X, Tong Y, Yang R, Wang Y, Cao S, et al. Development and validation of a tuberculosis medication adherence scale. PloS One. 2012;7, e50328.
4. Chaulk CP, Kazandjian VA. Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus Statement of the Public Health Tuberculosis Guidelines Panel. JAMA. 1998;279:943-8.
5. Zhang LX, Tu DH, An YS, Enarson DA. The impact of migrants on the epidemiology of tuberculosis in Beijing, China. Int J Tuberc Lung Dis. 2006;10:959-62.
6. Li T, He XX, Chang ZR, Ren YH, Zhou JY, Ju LR, et al. Impact of new migrant populations on the spatial distribution of tuberculosis in Beijing. Int J Tuberc Lung Dis. 2011;15:163-8.
7. National Health and Family Planning Commission of the People's Republic of China. Report on China's migrant population development (2013). Beijing: China Population Publishing House; 2013.
8. Wang L, Liu J, Chin DP. Progress in tuberculosis control and the evolving public-health system in China. Lancet. 2007;369:691-6.
9. Bureau of Statistics of the Shenzhen Municipality. The Shenzhen statistics yearbook 2013. Shenzhen: China Statistics Press; 2013.
10. Xiao SY. Theory basis and application of the social support rating scale. J Clin Psychiatry. 1994;4:98-100.
11. Lin QH, Jiang CQ, Lam TH. The relationship between occupational stress, burnout, and turnover intention among managerial staff from a Sino-Japanese joint venture in Guangzhou, China. J Occup Health. 2013;55:458-67.
12. Xu J, Wei Y. Social support as a moderator of the relationship between anxiety and depression: an empirical study with adult survivors of Wenchuan earthquake. PloS one. 2013;8, e79045.
13. Zhou C, Chu J, Liu J, Gai Tobe R, Gen H, Wang X, et al. Adherence to tuberculosis treatment among migrant pulmonary tuberculosis patients in Shandong, China: a quantitative survey study. PloS one. 2012;7, e52334.
14. Hu D, Liu X, Chen J, Wang Y, Wang T, Zeng W, et al. Direct observation and adherence to tuberculosis treatment in Chongqing, China: a descriptive study. Health Policy Plan. 2008;23:43-55.
15. Yao S, Huang WH, van den Hof S, Yang SM, Wang XL, Chen W, et al. Treatment adherence among sputum smear-positive pulmonary tuberculosis patients in mountainous areas in China. BMC Health Serv Res. 2011;11:341.
16. Xu W, Lu W, Zhou Y, Zhu L, Shen H, Wang J. Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study. BMC Health Serv Res. 2009;9:169.
17. Frieden T. What is intermittent treatment and what is the scientific basis for intermittency. In: Frieden T, editor. Toman's tuberculosis case detection, treatment, and mmonitoring. 2nd ed. Geneva: World Health Organization; 2004. p. 130-8.
18. Driver CR, Matus SP, Bayuga S, Winters AI, Munsiff SS. Factors associated with tuberculosis treatment interruption in New York City. J Public Health Manag Pract. 2005;11:361-8.
19. Thiam S, LeFevre AM, Hane F, Ndiaye A, Ba F, Fielding KL, et al. Effectiveness of a strategy to improve adherence to tuberculosis treatment in a resource-poor setting: a cluster randomized controlled trial. JAMA. 2007;297:380-6.
20. Liam CK, Lim KH, Wong CM, Tang BG. Attitudes and knowledge of newly diagnosed tuberculosis patients regarding the disease, and factors affecting treatment compliance. Int J Tuberc Lung Dis. 1999;3:300-9.
21. Menzies R, Rocher I, Vissandjee B. Factors associated with compliance in treatment of tuberculosis. Tuber lung dis. 1993;74:32-7.
22. Mishra P, Hansen EH, Sabroe S, Kafle KK. Socio-economic status and adherence to tuberculosis treatment: a case-control study in a district of Nepal. Int J Tuberc Lung Dis. 2005;9:1134-9.